408 related articles for article (PubMed ID: 35760999)
1. Liquid Biopsies: Flowing Biomarkers.
Hyenne V; Goetz JG; Osmani N
Adv Exp Med Biol; 2022; 1379():341-368. PubMed ID: 35760999
[TBL] [Abstract][Full Text] [Related]
2. Longitudinal Multi-Parametric Liquid Biopsy Approach Identifies Unique Features of Circulating Tumor Cell, Extracellular Vesicle, and Cell-Free DNA Characterization for Disease Monitoring in Metastatic Breast Cancer Patients.
Keup C; Suryaprakash V; Storbeck M; Hoffmann O; Kimmig R; Kasimir-Bauer S
Cells; 2021 Jan; 10(2):. PubMed ID: 33494385
[TBL] [Abstract][Full Text] [Related]
3. The role of extracellular vesicles in circulating tumor cell-mediated distant metastasis.
Guo S; Huang J; Li G; Chen W; Li Z; Lei J
Mol Cancer; 2023 Nov; 22(1):193. PubMed ID: 38037077
[TBL] [Abstract][Full Text] [Related]
4. Extracellular vesicles as a novel source of biomarkers in liquid biopsies for monitoring cancer progression and drug resistance.
Vasconcelos MH; Caires HR; Ābols A; Xavier CPR; Linē A
Drug Resist Updat; 2019 Dec; 47():100647. PubMed ID: 31704541
[TBL] [Abstract][Full Text] [Related]
5. Extracellular vesicles for personalized therapy decision support in advanced metastatic cancers and its potential impact for prostate cancer.
Soekmadji C; Corcoran NM; Oleinikova I; Jovanovic L; ; Ramm GA; Nelson CC; Jenster G; Russell PJ
Prostate; 2017 Oct; 77(14):1416-1423. PubMed ID: 28856701
[TBL] [Abstract][Full Text] [Related]
6. Human Plasma Extracellular Vesicle Isolation and Proteomic Characterization for the Optimization of Liquid Biopsy in Multiple Myeloma.
Reale A; Khong T; Xu R; Chen M; Mithraprabhu S; Bingham N; Spencer A; Greening DW
Methods Mol Biol; 2021; 2261():151-191. PubMed ID: 33420989
[TBL] [Abstract][Full Text] [Related]
7. Extracellular Vesicles and Circulating Tumour Cells - complementary liquid biopsies or standalone concepts?
Słomka A; Wang B; Mocan T; Horhat A; Willms AG; Schmidt-Wolf IGH; Strassburg CP; Gonzalez-Carmona MA; Lukacs-Kornek V; Kornek MT
Theranostics; 2022; 12(13):5836-5855. PubMed ID: 35966579
[TBL] [Abstract][Full Text] [Related]
8. The Present and Future of Liquid Biopsies in Non-Small Cell Lung Cancer: Combining Four Biosources for Diagnosis, Prognosis, Prediction, and Disease Monitoring.
Bracht JWP; Mayo-de-Las-Casas C; Berenguer J; Karachaliou N; Rosell R
Curr Oncol Rep; 2018 Jul; 20(9):70. PubMed ID: 30030656
[TBL] [Abstract][Full Text] [Related]
9. Development and Application of Liquid Biopsies in Metastatic Prostate Cancer.
Morrison GJ; Goldkorn A
Curr Oncol Rep; 2018 Mar; 20(4):35. PubMed ID: 29572775
[TBL] [Abstract][Full Text] [Related]
10. Circulating tumor cell as the functional aspect of liquid biopsy to understand the metastatic cascade in solid cancer.
Cortés-Hernández LE; Eslami-S Z; Alix-Panabières C
Mol Aspects Med; 2020 Apr; 72():100816. PubMed ID: 31377345
[TBL] [Abstract][Full Text] [Related]
11. Molecular Profiling of Liquid Biopsies for Precision Oncology.
Gonzalez-Kozlova EE
Adv Exp Med Biol; 2022; 1361():235-247. PubMed ID: 35230692
[TBL] [Abstract][Full Text] [Related]
12. Liquid biopsy and their application progress in head and neck cancer: focus on biomarkers CTCs, cfDNA, ctDNA and EVs.
Meng Y; Bian L; Zhang M; Bo F; Lu X; Li D
Biomark Med; 2020 Oct; 14(14):1393-1404. PubMed ID: 33073579
[TBL] [Abstract][Full Text] [Related]
13. Liquid biopsies in pancreatic cancer.
Kamyabi N; Bernard V; Maitra A
Expert Rev Anticancer Ther; 2019 Oct; 19(10):869-878. PubMed ID: 31533487
[No Abstract] [Full Text] [Related]
14. Comparative application of microfluidic systems in circulating tumor cells and extracellular vesicles isolation; a review.
Adriani RR; Gargari SLM
Biomed Microdevices; 2022 Dec; 25(1):4. PubMed ID: 36574057
[TBL] [Abstract][Full Text] [Related]
15. Emerging Nanotechnologies for Liquid Biopsy: The Detection of Circulating Tumor Cells and Extracellular Vesicles.
Li W; Wang H; Zhao Z; Gao H; Liu C; Zhu L; Wang C; Yang Y
Adv Mater; 2019 Nov; 31(45):e1805344. PubMed ID: 30589111
[TBL] [Abstract][Full Text] [Related]
16. Extracellular Vesicles, Circulating Tumor Cells, and Immune Checkpoint Inhibitors: Hints and Promises.
Bandini S; Ulivi P; Rossi T
Cells; 2024 Feb; 13(4):. PubMed ID: 38391950
[TBL] [Abstract][Full Text] [Related]
17. Liquid biopsy: possibilities and limitations in uro-oncology.
López-Guerrero JA; Pastor-Navarro B; Claramunt-Alonso R; García-Flores M; Rubio-Briones J
Arch Esp Urol; 2022 Mar; 75(2):203-214. PubMed ID: 35332890
[TBL] [Abstract][Full Text] [Related]
18. Liquid Biopsy in Lung Cancer: Biomarkers for the Management of Recurrence and Metastasis.
Souza VGP; Forder A; Brockley LJ; Pewarchuk ME; Telkar N; de Araújo RP; Trejo J; Benard K; Seneda AL; Minutentag IW; Erkan M; Stewart GL; Hasimoto EN; Garnis C; Lam WL; Martinez VD; Reis PP
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240238
[TBL] [Abstract][Full Text] [Related]
19. The potential of liquid biopsies in gastrointestinal cancer.
Wu C; Zhang J; Li H; Xu W; Zhang X
Clin Biochem; 2020 Oct; 84():1-12. PubMed ID: 32540214
[TBL] [Abstract][Full Text] [Related]
20. Fugitives on the run: circulating tumor cells (CTCs) in metastatic diseases.
Mamdouhi T; Twomey JD; McSweeney KM; Zhang B
Cancer Metastasis Rev; 2019 Jun; 38(1-2):297-305. PubMed ID: 31053984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]